Showing results (131-140 of 1,144) with videos related to
Sort By:
Pageof 115
Il Farmaco; Edizione Scientifica|March 1, 1986
Study of the nicotinic activity of very potent muscarinic agentsA Lucchelli, C Boselli, E GranaIl Farmaco; Edizione Scientifica|June 1, 1977
[Selectivity of beta-adrenergic compounds. IV. Studies on 1-(4'-methylphenyl)-2-isopropylaminopropanol]A Lucchelli, E Grana, F ZontaThe Journal of Pharmacy and Pharmacology|February 1, 1989
Distribution of dissociation constant values of muscarinic agonistsA Lucchelli, C Boselli, E GranaProceedings of the National Academy of Sciences of the United States of America|April 18, 1998
Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamineV Uzunova, Y Sheline, J M Davis, et al.Proceedings of the National Academy of Sciences of the United States of America|August 23, 2005
Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophreniaE Dong, R C Agis-Balboa, M V Simonini, et al.The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
gamma-Aminobutyric acidA receptor heterogeneity in rat central nervous system: studies with clonazepam and other benzodiazepine ligandsM Massotti, J L Schlichting, M D Antonacci, et al.Neuropharmacology|November 9, 2002
GABAA receptors and benzodiazepines: a role for dendritic resident subunit mRNAsE Costa, J Auta, D R Grayson, et al.Life Sciences|January 1, 1993
Topology of two DBI receptors in human lymphocytesA Berkovich, C Ferrarese, G Cavaletti, et al.Critical Reviews in Neurobiology|December 8, 2004
A GABAergic cortical deficit dominates schizophrenia pathophysiologyE Costa, J M Davis, E Dong, et al.Proceedings of the National Academy of Sciences of the United States of America|January 25, 2006
The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylasesM V Simonini, L M Camargo, E Dong, et al.Pageof 115